Chronic lymphocytic leukaemia: a model for investigating potential new targets for the therapy of indolent lymphomas

被引:6
作者
Caligaris-Cappio, F [1 ]
Cignetti, A
Granziero, L
Ghia, P
机构
[1] Univ Turin, Dept Oncol Sci, Div Clin Immunol & Haematol, Osped Mauriziano Umberto I, Turin, Italy
[2] IRCC, Lab Tumour Immunol, Candiolo, TO, Italy
关键词
chronic lymphocytic leukaemia; indolent lymphomas; B lymphocytes; apoptosis; microenvironment;
D O I
10.1053/beha.2002.0212
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We address two key issues whose investigation may help to define new prognostic parameters and new potential targets for therapeutic intervention. First, which are the conceptual implications of the cellular origin of indolent lymphomas? Second, how may deciphering the biology of chronic lymphocytic leukaemia (CLL) lead to the development of new modalities of treatment? The latter issue is articulated in the following three key questions. (1) Which are the molecular pathways through which the microenvironment exerts its influence on the malignant clone? (2) What are the relationships between proliferation and defective apoptosis? (3)ls there any evidence of a role for antigenic stimulation?
引用
收藏
页码:563 / 575
页数:13
相关论文
共 95 条
[1]   Variable heavy chain gene analysis of follicular lymphomas: correlation between heavy chain isotype expression and somatic mutation load [J].
Aarts, WM ;
Bende, RJ ;
Steenbergen, EJ ;
Kluin, PM ;
Ooms, ECM ;
Pals, ST ;
van Noesel, CJM .
BLOOD, 2000, 95 (09) :2922-2929
[2]  
Adida C, 2000, BLOOD, V96, P1921
[3]   Angiogenesis in acute and chronic leukemias and myelodysplastic syndromes [J].
Aguayo, A ;
Kantarjian, H ;
Manshouri, T ;
Gidel, C ;
Estey, E ;
Thomas, D ;
Koller, C ;
Estrov, Z ;
O'Brien, S ;
Keating, M ;
Freireich, E ;
Albitar, M .
BLOOD, 2000, 96 (06) :2240-2245
[4]   An alternatively spliced form of CD79b gene may account for altered B-cell receptor expression in B-chronic lymphocytic leukemia [J].
Alfarano, A ;
Indraccolo, S ;
Circosta, P ;
Minuzzo, S ;
Vallario, A ;
Zamarchi, R ;
Fregonese, A ;
Calderazzo, F ;
Faldella, A ;
Aragno, M ;
Camaschella, C ;
Amadori, A ;
Caligaris-Cappio, F .
BLOOD, 1999, 93 (07) :2327-2335
[5]   A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma [J].
Ambrosini, G ;
Adida, C ;
Altieri, DC .
NATURE MEDICINE, 1997, 3 (08) :917-921
[6]  
ANDREEFF M, 1980, BLOOD, V55, P282
[7]   CLONAL EVOLUTION OF A FOLLICULAR LYMPHOMA - EVIDENCE FOR ANTIGEN SELECTION [J].
BAHLER, DW ;
LEVY, R .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (15) :6770-6774
[8]  
BERGUI L, 1994, LEUKEMIA, V8, P1245
[9]   CD40-activated B-cell chronic lymphocytic leukemia cells for tumor immunotherapy: Stimulation of allogeneic versus autologous T cells generates different types of effector cells [J].
Buhmann, R ;
Nolte, A ;
Westhaus, D ;
Emmerich, B ;
Hallek, M .
BLOOD, 1999, 93 (06) :1992-2002
[10]  
Burger JA, 2000, BLOOD, V96, P2655